A recently retired Executive Director from Novartis (NIBR) with over 30 years of experience in pharmaceutical research. He is a scientist with a Ph. D. from the University of Basel, specializing in preclinical drug discovery, structural biology, and cross-functional portfolio management, particularly with proteases and kinases.
He is passionate about drugging targets previously believed to be undruggable, celebrating the success story of the first Factor B inhibitor as a major scientific achievement.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.